Besides the aforementioned autoimmune diseases, recent study on genetic mutations related to glycosylation pathway in colorectal cancer also demonstrated that B3GNT2 mutations are enriched in tumor tissues and patient-derived cell lines (31). This evidence concerns the gene B3GNT2 and neoplasm.